- Report
- May 2025
- 100 Pages
Global
From €5223EUR$5,950USD£4,544GBP
- Report
- September 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- March 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,779GBP
- Report
- September 2025
- 101 Pages
Global
From €3500EUR$4,271USD£3,152GBP
- Report
- February 2021
- 420 Pages
United States
From €1369EUR$1,560USD£1,191GBP
€2107EUR$2,400USD£1,833GBP
- Report
- January 2024
- 200 Pages
Global
From €4389EUR$5,000USD£3,818GBP
- Report
- May 2024
- 140 Pages
Global
From €3510EUR$3,999USD£3,054GBP
Zyprexa (olanzapine) is a medication used to treat mental disorders such as schizophrenia, bipolar disorder, and depression. It is an atypical antipsychotic drug, meaning it works differently than traditional antipsychotics. Zyprexa works by blocking certain receptors in the brain, which helps to reduce symptoms of mental illness. It is available in both oral and injectable forms.
Zyprexa is one of the most commonly prescribed medications for mental disorders. It is used to treat a wide range of mental health conditions, including schizophrenia, bipolar disorder, and depression. It is also used to treat symptoms of anxiety and agitation.
The Zyprexa market is highly competitive, with many companies offering similar products. Some of the major players in the market include Eli Lilly, Pfizer, Novartis, and AstraZeneca. These companies offer a variety of formulations of Zyprexa, including tablets, capsules, and injections. Other companies in the market include Sun Pharmaceuticals, Teva Pharmaceuticals, and Mylan. Show Less Read more